The completion of the human genome sequence marks a major milestone in genomics, ushering in the genomic era. The Human Genome Project (HGP), initiated in 1990, has achieved its goals ahead of schedule, leading to a revolution in biological research. The new research strategies and technologies have generated vast genomic datasets, transforming the study of all life processes. Genomics has become a central discipline in biomedical research, offering improved tools for understanding biological functions at an unprecedented level of molecular detail. The practical implications of genomics are evident. Identifying genes responsible for Mendelian diseases, once a complex task, is now routine. The sequencing of the mouse genome has simplified the identification of mutations underlying various phenotypes. Comparative analysis of human and mouse genomes has revealed that a larger proportion of the mammalian genome is under evolutionary selection than previously thought. Microarray technologies have enabled the study of thousands of genes in a short time, and clinical opportunities for gene-based pre-symptomatic prediction and drug response are emerging. The HGP's investment in ethical, legal, and social implications has created a skilled cohort of scholars and increased public awareness. The vision for the future of genomics research is broader and more ambitious than earlier plans. It emphasizes the need for a comprehensive catalog of all genome-encoded components, understanding how genomes change and take on new functions, and developing strategies to identify genetic contributions to disease and drug response. The vision also includes the development of genome-based approaches for predicting disease susceptibility, early detection of illness, and molecular classification of disease states. It calls for the creation of a molecular taxonomy of illness based on detailed molecular characterization, which would replace current empirical classification schemes. The vision also emphasizes the importance of ethical, legal, and social implications (ELSI) in genomics research. It calls for the development of policies that facilitate the widespread use of genome information in research and clinical settings. It highlights the need for education and training to ensure that health professionals and the public understand the interplay of genetic and environmental factors in health and disease. The vision also emphasizes the importance of diverse representation in genomics research to ensure that all populations benefit from genomic advances. The report outlines several grand challenges for the future of genomics research, including the comprehensive identification of structural and functional components of the human genome, the elucidation of genetic networks and protein pathways, the development of detailed understanding of heritable variation, the understanding of evolutionary variation across species, and the development of policy options for the widespread use of genome information. It also emphasizes the need for new technologies, computational biology, and interdisciplinary collaboration to achieve these goals. The vision calls for a focus on the translation of genomic information into therapeutic advances and the development of new therapeutic approaches to disease. It also highlights the importance of education and training to ensure that genomics is used effectively for the benefit of all.The completion of the human genome sequence marks a major milestone in genomics, ushering in the genomic era. The Human Genome Project (HGP), initiated in 1990, has achieved its goals ahead of schedule, leading to a revolution in biological research. The new research strategies and technologies have generated vast genomic datasets, transforming the study of all life processes. Genomics has become a central discipline in biomedical research, offering improved tools for understanding biological functions at an unprecedented level of molecular detail. The practical implications of genomics are evident. Identifying genes responsible for Mendelian diseases, once a complex task, is now routine. The sequencing of the mouse genome has simplified the identification of mutations underlying various phenotypes. Comparative analysis of human and mouse genomes has revealed that a larger proportion of the mammalian genome is under evolutionary selection than previously thought. Microarray technologies have enabled the study of thousands of genes in a short time, and clinical opportunities for gene-based pre-symptomatic prediction and drug response are emerging. The HGP's investment in ethical, legal, and social implications has created a skilled cohort of scholars and increased public awareness. The vision for the future of genomics research is broader and more ambitious than earlier plans. It emphasizes the need for a comprehensive catalog of all genome-encoded components, understanding how genomes change and take on new functions, and developing strategies to identify genetic contributions to disease and drug response. The vision also includes the development of genome-based approaches for predicting disease susceptibility, early detection of illness, and molecular classification of disease states. It calls for the creation of a molecular taxonomy of illness based on detailed molecular characterization, which would replace current empirical classification schemes. The vision also emphasizes the importance of ethical, legal, and social implications (ELSI) in genomics research. It calls for the development of policies that facilitate the widespread use of genome information in research and clinical settings. It highlights the need for education and training to ensure that health professionals and the public understand the interplay of genetic and environmental factors in health and disease. The vision also emphasizes the importance of diverse representation in genomics research to ensure that all populations benefit from genomic advances. The report outlines several grand challenges for the future of genomics research, including the comprehensive identification of structural and functional components of the human genome, the elucidation of genetic networks and protein pathways, the development of detailed understanding of heritable variation, the understanding of evolutionary variation across species, and the development of policy options for the widespread use of genome information. It also emphasizes the need for new technologies, computational biology, and interdisciplinary collaboration to achieve these goals. The vision calls for a focus on the translation of genomic information into therapeutic advances and the development of new therapeutic approaches to disease. It also highlights the importance of education and training to ensure that genomics is used effectively for the benefit of all.